MTA1 as a predictor for the progression of endometriosis.


MTA1 as a predictor for the progression of endometriosis.

MTA1 plays role in the progression of tumors, how about in endometriosis, which has tumor-like characteristics?

Key Points

Highlights:

  • MTA1 gene is highly correlated with prognosis of many tumors. The aim of this study is to show whether it has the same correlation with endometriosis progression and recurrence.

Importance:

  • Metastasis-associated gene MTA family has three molecular types named MTA1, MTA2, and MTA3. The importance of using MTA1 in immunochemistry analyses is due it's carboxyl-terminal which contains an SH3 structure that makes an interaction with signaling molecules.

What's done here:

  • To compare MTA1 existence in the normal, ectopic and eutopic endometrium samples, the authors studied immunochemistry and reverse transcription-PCR techniques.

Key results:

  • MTA1 has no relation with the proliferation and apoptosis of endometrium.
  • After determining MTA1 statistically higher levels (p<0.05)  in ectopic endometrium they indicate the role of the metastasis-associated gene in recurrence of endometriosis.
  • MTA1 mRNA and MTA1 protein levels are higher in stage III-IV endometriosis than in stage I-II that means MTA1 is directly related with the progression of endometriosis.
  • When results stratified by age, BMI, r-AFS grading, postoperative pregnancy, dysmenorrhea, and evaluated by the multivariate logistic regression model, high expression of MTA1 and rAFS stage were found to be significant risk factors for postoperative recurrence for ovarian endometriosis.

Lay Summary

Jing Zhang et al. from the Department of Obstetrics and Gynecology, Affiliated Haikou Hospital, Xiangya Medical College of Central South University, Hainan, China, published their article in the open access medical journal "Medicine". Their aim was to evaluate the relationship between endometriosis and tumor metastasis gene MTA1 to search its role on the progression and the recurrence of endometriosis.

The surgical and medical treatment combination for endometriosis improve the therapeutic effect in a short time period but recurrence cannot be avoided. Endometriosis is a benign disease but may progress or recur, in other words, may behave like a metastatic disease, thus the authors wanted to see the expression of a gene named MTA1 which is related to tumor metastasis.

Authors collected ectopic and eutopic endometrium samples of one hundred patients with endometriosis during their laparoscopic operations, they also obtained one hundred women's eutopic endometrium samples without endometriosis and compared the level of MTA1 by immunochemical and reverse transcription-PCR techniques. Half of the samples were in the proliferative phase while the other half were in their secretory phase during the laparoscopic operations, similar for both groups. 

The results showed that the tumor metastasis-associated gene MTA1 mRNA level is statistically elevated in the endometriosis (ectopic endometrium) (p<0.05), less elevated in the eutopic endometrium (p<0.05) and slightly detectable in normal endometrium samples.  There was no difference in the MTA1 expression level when the phase of the menstrual cycle was taken into the account. On the other hand, when the stage of endometriosis was considered, mRNA and MTA1 protein levels were directly proportional to the stage of the endometriosis. Finally, multivariate logistic regression analysis revealed that the high expression of MTA1 and endometriosis stage were independent risk factors for postoperative recurrence for ovarian endometriosis.

Authors concluded that MTA1 protein is involved in the development of endometriosis and suggested to use the MTA1 expression as a molecular marker to predict the progression of endometriosis.


Research Source: https://www.ncbi.nlm.nih.gov/pubmed/30170442


immunochemistry metastasis-associated gene recurrence reverse transcription mRNA MTA1 endometriosis

DISCLAIMER

Endonews is designed to strictly highlight the most recently published scientific research that focuses on endometriosis. It is not designed to provide medical advice or an opinion on the best form of treatment. We highly stress the importance of not using this site as a substitute for seeking an experienced physician, which is highly recommended if you have any questions or concerns regarding your endometriosis needs. We believe in the consciousness of our reader to discriminate that research is different than "standard of care," and trust that they can keep in mind that here at Endonews, we summarize the newest peer-reviewed scientific medical literature, without bias.